NASDAQ: GRML

Greenland Mines Ltd.

Basic Materials | Other Precious Metals

No licensed closing price on file for GRML. This page shows the company’s SEC filings and filed figures, without a price or any ratio that depends on one.

Greenland Mines Ltd. (NASDAQ: GRML) is a precious metals company. Figures from SEC EDGAR; updated 2026-11-02 23:19 UTC.

What Greenland Mines Ltd. does

Greenland Mines Ltd, formerly Klotho Neurosciences, develops medicines for chronic diseases including cancer, cardiovascular, and neurodegenerative disorders through multiple platforms: a generic drug portfolio, a biosimilar biologics platform for cancer treatment, and a proprietary gene therapy platform using Klotho to treat neurodegenerative diseases. The company has acquired market-approved anti-cancer drugs for colorectal, gastric, and lung cancer treatment, as well as off-patent bio-generic antibodies from Reliance Life Sciences.

Summarized from Greenland Mines Ltd.’s SEC filings · AI-generated analysis. Not investment advice. May contain errors. · Read the filing ↗

Key facts

Charts

Charts are in the appInteractive charts for GRML are available in Oxford Ledge.
Open GRML in Oxford Ledge →

SEC Filings

SEC EDGAR ↗

Recent Insider Activity

Source: SEC EDGAR · Filed 2026-03-06

Most recent filed transactions — March 2026:

2026-03-06DirectorAward350,000—
2026-03-06DirectorAward350,000—
2026-03-06Chief Executive OfficerAward2,500,000—

Top Institutional Holders (latest 13F)

Source: SEC EDGAR · As of 2026-Q2

METEORA CAPITAL, LLC5,373,755$1.77M+76767828.6%
CITADEL ADVISORS LLC5,165,648$1.34MNEW
VANGUARD CAPITAL MANAGEMENT LLC3,038,347$790.0K+426.3%

View QoQ ownership changes →Full institutional ownership →

Recent 8-K Events (parsed from SEC filings)All events →

Source: SEC EDGAR 8-K filings · Interpretation: Oxford Ledge parser · Confidence-filtered ≥ 0.50

2025-07-23Exec ChangeDeparture of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officersEstimatedSEC 8-K →
2024-10-31Exec ChangeDeparture of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officersJoseph SinkuleAuthoritativeSEC 8-K →
2024-08-30Exec ChangeDeparture of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officersEstimatedSEC 8-K →

Company news

View all →

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for GRML and 5,000+ tickers.

Create a free account — keep GRML

For your agent

GET /api/data?ticker=GRML

This page as JSON via rel="alternate" · REST API docs · MCP server (60 tools) · llms.txt